Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amrita Krishnan

Showing results (11-20 of 114) with videos related to

Pageof 12
Sort By:
Journal of the National Comprehensive Cancer Network : JNCCN|May 10, 2012
A case of diffuse large B-cell lymphoma in association with paraesophageal leiomyoma: highlighting false-positivity of PET scan and importance of tissue diagnosisRajinder S Grover, Kemp Kernstine, Amrita Krishnan
Clinical Lymphoma, Myeloma & Leukemia|May 17, 2025
SOHO State of the Art Updates and Next Questions | Manuscript Title: Bispecific T-Cell Engagers: Sequencing, B-Cell Maturation Antigen, GPRC5D, and ResistanceSabarish Ayyappan, Jeremy Larsen, James Sanchez, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|June 2, 2016
Moving Beyond Autologous Transplantation in Multiple Myeloma: Consolidation, Maintenance, Allogeneic Transplant, and Immune TherapyAmrita Krishnan, Ravi Vij, Jesse Keller, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 19, 2021
When and How to Treat Relapsed Multiple MyelomaNitya Nathwani, Luca Bertamini, Rahul Banerjee, et al.
Transfusion|April 24, 2013
Second time a charm? Remobilization of peripheral blood stem cells with plerixafor in patients who previously mobilized poorly despite using plerixafor as a salvage agentShan Yuan, Auayporn Nademanee, Amrita Krishnan, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 24, 2012
American Society of Blood and Marrow Transplantation Guidelines for Training in Hematopoietic Progenitor Cell TransplantationShakila Khan, Mark B Juckett, Krishna V Komanduri, et al.
Seminars in Hematology|September 26, 2024
Mobilizing CARs: Benefits, drawbacks, and directions for outpatient CAR T-cell therapyJennifer S Woo, Kim Nguyen, Lawrence Liu, et al.
Clinical Lymphoma, Myeloma & Leukemia|July 29, 2023
Expert Consensus on the Incorporation of Anti-CD38 Monoclonal Antibody Therapy Into the Management of Newly Diagnosed Multiple MyelomaSagar Lonial, Andrew D Bowser, Ajai Chari, et al.
Viruses|November 29, 2013
Development of hematopoietic stem cell based gene therapy for HIV-1 infection: considerations for proof of concept studies and translation to standard medical practiceDavid L DiGiusto, Rodica Stan, Amrita Krishnan, et al.
Clinical Lymphoma, Myeloma & Leukemia|April 7, 2020
Graft-Versus-Host Disease in Multiple Myeloma Patients Treated With Daratumumab After Allogeneic TransplantationLiana Nikolaenko, Saurabh Chhabra, Noa Biran, et al.
Pageof 12

Showing results (11-20 of 114) with videos related to

Sort By:
Pageof 12
Journal of the National Comprehensive Cancer Network : JNCCN|May 10, 2012
A case of diffuse large B-cell lymphoma in association with paraesophageal leiomyoma: highlighting false-positivity of PET scan and importance of tissue diagnosisRajinder S Grover, Kemp Kernstine, Amrita Krishnan
Clinical Lymphoma, Myeloma & Leukemia|May 17, 2025
SOHO State of the Art Updates and Next Questions | Manuscript Title: Bispecific T-Cell Engagers: Sequencing, B-Cell Maturation Antigen, GPRC5D, and ResistanceSabarish Ayyappan, Jeremy Larsen, James Sanchez, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|June 2, 2016
Moving Beyond Autologous Transplantation in Multiple Myeloma: Consolidation, Maintenance, Allogeneic Transplant, and Immune TherapyAmrita Krishnan, Ravi Vij, Jesse Keller, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 19, 2021
When and How to Treat Relapsed Multiple MyelomaNitya Nathwani, Luca Bertamini, Rahul Banerjee, et al.
Transfusion|April 24, 2013
Second time a charm? Remobilization of peripheral blood stem cells with plerixafor in patients who previously mobilized poorly despite using plerixafor as a salvage agentShan Yuan, Auayporn Nademanee, Amrita Krishnan, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 24, 2012
American Society of Blood and Marrow Transplantation Guidelines for Training in Hematopoietic Progenitor Cell TransplantationShakila Khan, Mark B Juckett, Krishna V Komanduri, et al.
Seminars in Hematology|September 26, 2024
Mobilizing CARs: Benefits, drawbacks, and directions for outpatient CAR T-cell therapyJennifer S Woo, Kim Nguyen, Lawrence Liu, et al.
Clinical Lymphoma, Myeloma & Leukemia|July 29, 2023
Expert Consensus on the Incorporation of Anti-CD38 Monoclonal Antibody Therapy Into the Management of Newly Diagnosed Multiple MyelomaSagar Lonial, Andrew D Bowser, Ajai Chari, et al.
Viruses|November 29, 2013
Development of hematopoietic stem cell based gene therapy for HIV-1 infection: considerations for proof of concept studies and translation to standard medical practiceDavid L DiGiusto, Rodica Stan, Amrita Krishnan, et al.
Clinical Lymphoma, Myeloma & Leukemia|April 7, 2020
Graft-Versus-Host Disease in Multiple Myeloma Patients Treated With Daratumumab After Allogeneic TransplantationLiana Nikolaenko, Saurabh Chhabra, Noa Biran, et al.
Pageof 12